Treatment of The Common Cold: Acute Upper Respiratory Tract Infection
Treatment of The Common Cold: Acute Upper Respiratory Tract Infection
Acute upper respiratory tract infections are extremely common in adults and children, but only a few safe and effective treat-
ments are available. Patients typically present with nasal congestion, rhinorrhea, sore throat, cough, general malaise, and/or
low-grade fever. Informing patients about the self-limited nature of the common
cold can help manage expectations, limit antibiotic use, and avoid over-the-
counter purchases that may not help. Treatments with proven effectiveness for
cold symptoms in adults include over-the-counter analgesics, zinc, nasal decon-
gestants with or without antihistamines, and ipratropium for cough. Lower-quality
evidence suggests that Lactobacillus casei may be beneficial in older adults. The
only established safe and effective treatments for children are acetylcysteine,
Acute upper respiratory tract infection (URI), also reduction of symptom duration and severity. Over-the-
called the common cold, is the most common acute illness counter cold medications should not be used to treat chil-
in the United States and the industrialized world.1 Patients dren younger than four years because of lack of benefit and
typically present with nasal congestion, rhinorrhea, sore low but significant mortality rates associated with their use
throat, cough, general malaise, and/or low-grade fever. in this population.5,6 Informing patients about the natural
Symptoms are self-limited, often lasting up to 10 days. In course of the common cold can help manage expectations,
children, the median duration is eight days in those who limit antibiotic use,7 and avoid unnecessary over-the-
receive medical care, and 90% of cases resolve within counter purchases (Table 2).
23 days.2 Viruses such as rhinovirus are the predominant
cause of acute URI;transmission occurs through contact
BEST PRACTICES IN INFECTIOUS DISEASES
with the nasal secretions and saliva of infected people.3 The
common cold should be distinguished from allergic rhini-
tis, isolated pharyngitis, acute bronchitis (which generally Recommendations from the Choosing
has a longer duration, with a mean of 18 days in adults Wisely Campaign
and 12 days in children2,4), influenza, bacterial sinusitis, Recommendation Sponsoring organization
and pertussis (Table 1). The primary goals of treatment are
Antibiotics should not be used for American Academy
apparent viral respiratory illnesses of Pediatrics
(sinusitis, pharyngitis, bronchitis).
CME This clinical content conforms to AAFP criteria for con-
tinuing medical education (CME). See CME Quiz on page 271. Avoid prescribing antibiotics for Infectious Diseases
upper respiratory infections. Society of America
Author disclosure: No relevant financial affiliations.
Patient information: Handouts on this topic, written by the Source: For more information on the Choosing Wisely Campaign,
authors of this article, are available at [Link] [Link]/ see [Link] [Link]. For supporting citations and
afp/2019/0901/[Link] and [Link] [Link]/ to search Choosing Wisely recommendations relevant to primary
afp/2019/0901/[Link]. care, see [Link] [Link]/afp/recommendations/[Link].
Downloaded
September 1,from the◆American
2019 Volume Family Physician5 website at [Link]/afp.
100, Number Copyright © 2019 American Academy of Family
[Link]/afp American Family
Physicians. Physician
For the 281
private, noncom-
mercial use of one individual user of the website. All other rights reserved. Contact copyrights@[Link] for copyright questions and/or permission requests.
COMMON COLD
Evidence
Clinical recommendation rating Comments
Over-the-counter cold medications should not be used in children B Lack of benefit in 10 RCTs in children and
younger than four years because of potential harms and lack of observational studies of adverse effects
benefit. 5,6
The use of hand sanitizer or hand washing is the most effective way B Systematic review of cluster RCTs and observa-
to prevent the common cold.8,9 tional studies with variable risk of bias
Treatments with established effectiveness for cold symptoms in adults B Systematic reviews of RCTs of varying quality
are limited to over-the-counter analgesics and decongestants with or
without antihistamines (but not antihistamine monotherapy).6,22,25,27,31
Antibiotics are ineffective for treatment of the common cold in adults A Consistent findings of no benefit and increased
and children and should not be prescribed.46,47 adverse effects in systematic reviews of 11 RCTs
Codeine and other antitussives have not been proven effective for B Systematic reviews and a clinical practice
cough in adults.6,48,54 guideline from the American College of Chest
Physicians
Safe and effective treatments for cold symptoms in children include B Systematic reviews of RCTs of varying quality
nasal saline irrigation, menthol rub, and honey (for children 12
months and older). 39,61,63,65
TABLE 1
Acute Gradual Prominent, per- Common None or low Uncommon Mild Common
bronchitis sistent, dry or wet grade
Allergic Gradual Common, chronic Possible, especially None Common, None Common
rhinitis on awakening prominent
Common Gradual Common, dry Common None or low Common Mild Common
cold grade
Pertussis Gradual Prominent, parox- Uncommon None or low Uncommon Uncommon Uncommon
ysmal, whoop-like grade
282 American Family Physician [Link]/afp Volume 100, Number 5 ◆ September 1, 2019
TABLE 2
September 1, 2019 ◆ Volume 100, Number 5 [Link]/afp American Family Physician 283
COMMON COLD
TABLE 3
Acetaminophen 500 to 1,000 mg Single dose Cochrane review without data pooling of 4 low- to moderate-
quality trials with outcome assessment at 3 to 6 hours found
improvement in nasal obstruction and rhinorrhea but not in
other symptoms;no numeric data provided 22
Antihistamine plus Varies Variable Cochrane review of 12 trials, including 6 placebo controlled
decongestant with pooled data, found odds ratio of treatment failure = 0.27
(95% CI, 0.15 to 0.50);number needed to treat = 4, but 41%
favorable response in placebo group 23
Intranasal ipratro- 4 20-g puffs 4 times 3 weeks One small, randomized, double-blind crossover trial (N = 14)
pium (Atrovent) per day found significant reduction in persistent cough 24
Intranasal 2 sprays (0.05%) per Up to 10 days Cochrane review of 15 trials (N = 1,838) found no improvement
oxymetazoline nostril 1 or 2 times in nasal congestion with single use, but small improvement vs.
per day placebo after multiple doses (SMD = 0.49;95% CI, 0.07 to 0.92)25
Lactobacillus 200 g per day of fer- 3 months RCT of 1,072 older adults found significant improvement in
casei (for older mented dairy product duration of colds and in cumulative days with colds when
adults) containing L. casei taken daily 26
Nonsteroidal Varies Varies from single Cochrane review of 9 moderate-quality RCTs (N = 1,069) found
anti-inflammatory dose to 7 days no effect on total symptom score or cough, but improved
drugs sneezing (SMD = −0.44;95% CI, −0.75 to −0.12), headache
(SMD = –0.65;95% CI, –1.11 to –0.19), and ear, muscle, and
joint pain (SMD = –0.40;95% CI, –0.77 to –0.03) vs. placebo 27
Zinc acetate or Varies;typically 80 to Start within 3 days of 3 systematic reviews and meta-analyses found similar
gluconate 92 mg per day symptom onset and improvement in symptom duration (by about one-third) and
continue as long as mixed conclusions on symptom severity 28-30
symptoms persist
adults.24,36 Inhaled ipratropium in combination with salbu- hyponatremia.40 Good evidence is similarly lacking for ace-
tamol (a short-acting beta agonist that is not available in tylcysteine,41 garlic,42,43 and Chinese medicinal herbs.44,45
the United States) improves cough during the first 10 days
of treatment, but there is no benefit at 20 days compared INEFFECTIVE TREATMENTS
with placebo.37 There are more ineffective treatments for the common cold
Complementary and Alternative Treatments. Several than effective treatments, and some may even be harmful
meta-analyses and a randomized controlled trial suggest (Table 4).6,16,19,34,46-54 Treatments that are not recommended
that taking at least 75 mg of zinc acetate or gluconate loz- include antibiotics, antivirals, most cough medications, anti-
enges per day relieves cough and nasal discharge more histamine monotherapy, intranasal corticosteroids, steam,
quickly when treatment is started within 24 hours of symp- vitamins D and E, echinacea, and Pelargonium sidoides (Afri-
tom onset.28-30,38 Probiotics may have a role in the treatment can geranium).
of URIs. A randomized controlled trial showed that three Antibiotics. Antibiotics have no role in the treatment of the
months of daily use of a fermented dairy product contain- common cold. They do not reduce the severity or duration of
ing Lactobacillus casei reduced the duration of URI symp- symptoms, even when purulent rhinitis is present.46,47 Anti-
toms by 1.5 days in older adults.26 biotic prescriptions for patients with URI are a major source
of inappropriate prescribing in the outpatient setting.55
TREATMENTS WITH UNCERTAIN BENEFIT Informing patients about the natural course of URIs and rec-
Although nasal saline irrigation is effective for the treat- ommending appropriate treatments will improve antibiotic
ment of chronic rhinosinusitis, only low-quality evidence stewardship in the United States.7
supports its benefit in URIs.39 Increased fluid intake is Antihistamine Monotherapy. When used alone, antihista-
commonly recommended, but low-quality data suggest mines are no more effective than placebo for the treatment of
that it may not provide benefit and in rare cases can cause cold symptoms.6,34
284 American Family Physician [Link]/afp Volume 100, Number 5 ◆ September 1, 2019
COMMON COLD
September 1, 2019 ◆ Volume 100, Number 5 [Link]/afp American Family Physician 285
COMMON COLD
Acetylcysteine. The mucolytic acetylcysteine may safely nasal congestion and reduce nighttime cough frequency
decrease cough after six to seven days in children two years and severity, improving sleep for both the child and par-
and older.41 ents.64 The use of menthol alone may also improve perceived
Ipratropium. Intranasal ipratropium may decrease rhi- nasal patency but may not help with cough.65 Menthol is
norrhea but not congestion related to URIs in children safe for use in children two years and older. The use of
five years and older. It should not be used in children honey before bedtime may also reduce the frequency and
younger than five years. The main adverse effects are nose- severity of cough.60,61 Honey should not be given to chil-
bleeds, nasal dryness, and headache, although these are dren younger than 12 months because of the risk of expo-
self-limited.62 sure to botulinum spores.
Nasal Saline Irrigation. One large trial found that chil-
dren who use saline nasal washes six times per day have TREATMENTS WITH UNCERTAIN BENEFIT
faster resolution of nasal secretions and nasal obstruction The use of antihistamines, either alone or in combination
and reduced use of antipyretics, decongestants, and antibi- with a decongestant, is no more effective than placebo,
otics.63 This regimen also reduces school absences. and the risk of harm is significant.6 There is insufficient
Complementary and Alternative Treatments. Application evidence on the use of oral or intranasal decongestants as
of ointment containing camphor, menthol, and eucalyptus monotherapy for symptoms of the common cold in chil-
oils on the chest and neck of children at bedtime can relieve dren.25 Guaifenesin and other expectorants have not been
TABLE 5
Honey 2 to 5 years 2.5 mL Once 2 Cochrane reviews and 1 RCT found significant reduction
6 to 11 years 5 mL Once in symptoms 6,60,61
12 to 18 years 10 mL Once
Intranasal 5 to 11 years 2 sprays (0.03% or First 2 to Cochrane review of 7 RCTs (N = 2,144) without meta-
ipratropium 0.6%) per nostril 3 3 days of analysis showed significant reduction in rhinorrhea but not
(Atrovent) or 4 times per day symptoms nasal congestion vs. placebo62
Nasal saline 6 to 10 years 3 to 9 mL per Up to RCT (N = 401) showed improved resolution of nasal
irrigation nostril 3 weeks symptoms; reduced use of antipyretics, mucolytics, and anti-
biotics; and fewer days missed from school (P < .05 for all)63
Ointment con- 2 to 5 years 5 mL Once RCT (N = 138) found reduced cough, congestion, and sleep
taining camphor, 6 to 11 years 10 mL Once difficulty compared with petrolatum ointment or no treat-
menthol, and ment (P < .05 for all)64
eucalyptus oils
Vitamin C 0 to 18 years 1 to 2 g daily 40 days to 28 Cochrane review of 29 trials found no benefit for prevent-
weeks (typi- ing colds, but reduced symptom duration by 18% (about
cally about 1 to 2 days);starting vitamin C supplementation after symp-
3 months) tom onset does not reduce symptom duration 16
286 American Family Physician [Link]/afp Volume 100, Number 5 ◆ September 1, 2019
studied in this population. P. sidoides may help with symp- INEFFECTIVE TREATMENTS
toms of acute bronchitis in children, but it has not been Table 6 summarizes the evidence of ineffective treatments
studied in children with the common cold.51 Two small tri- for children with the common cold.6,18,31,46,47,49,69
als demonstrated little or no clinically significant benefit of Antibiotics. Antibiotics provide no benefit for URI symp-
zinc in children, even with frequent doses that were started toms in terms of severity or duration.46,47 There is no role
within 24 hours of symptom onset.66,67 A Cochrane review for antibiotics in the treatment of URIs in children.
that previously reported benefit of zinc in children has been Antitussives. Neither dextromethorphan nor codeine
withdrawn.68 relieves cough in children with URIs.70,71
Bronchodilators. In a randomized
controlled trial of 59 children without
TABLE 6
asthma, oral albuterol did not improve
Ineffective Treatments for Cold Symptoms in Children acute cough at seven days compared
with placebo, but it was associated with
Treatment Study type Findings
increased adverse effects.72 Beta ago-
Antibiotics 2 Cochrane reviews No benefit for symptom duration or nists have no benefit for cough in chil-
of 11 RCTs 46,47 severity compared with no antibiot- dren without airflow restriction.72,73
ics or placebo
Increased Fluid Intake. Low-quality
Antihistamine Cochrane review of No more effective than placebo for studies suggest that increasing fluid
monotherapy 3 RCTs 6 cough intake in children with URIs actually
Antihistamine plus Cochrane review of No more effective than placebo for
causes harm.40
decongestant 2 RCTs6 cough Intranasal and Oral Corticosteroids.
Intranasal corticosteroids do not reduce
Antitussives Cochrane review of No more effective than placebo for
symptom duration or severity in chil-
3 RCTs 6 cough
dren with the common cold;oral corti-
Antitussive plus Cochrane review of No more effective than placebo for costeroids have not been studied for the
bronchodilator RCTs 6 cough treatment of URIs in children.50,69
Echinacea Cochrane review of No benefit for symptom severity, Complementary and Alternative
RCTs 49 peak symptom severity, number of Treatments. Steam does not improve
days of fever, or parental report of cold symptoms in children, and cau-
severity compared with placebo
tion must be used to prevent burns.31
Intranasal Cochrane review of No decrease in episodes requiring Data do not support the use of vitamin
corticosteroids 2 studies 69 oral corticosteroids, emergency D18 or echinacea49,74 in children with
department visits, hospital admis-
sions, frequency of wheezing, or
the common cold.
duration of episodes This article updates previous articles
on this topic by Fashner, et al.,75 and by
Oral prednisolone RCT of a 5-day No significant difference in dura-
Simasek and Blandino.76
course 69 tion of hospitalization, time from
admission to discharge, mean 7-day
Data Sources: A primary search of
symptom score reported by parent,
or readmission for wheezing within 1
PubMed, the Cochrane database, the
month compared with placebo TRIP database, clinical guidelines from
the American College of Chest Physi-
Steam RCT of adults and No improvement in symptom sever- cians, the National Institute for Health and
children with subgroup ity with inhalation of steam for 5 Clinical Excellence, DynaMed Plus, and
analysis of 200 children minutes 3 times daily Essential Evidence Plus was completed
3 to 16 years of age31 using the key words cold, cough, respi-
ratory tract infection, upper respiratory
Vitamin D RCT of 703 children 1 2,000 IU of vitamin D did not reduce infection, nasal congestion, and rhinor-
to 5 years of age 18 overall respiratory infections com- rhea. We also searched the U.S. Food and
pared with 400 IU when taken daily
Drug Administration website for specific
for a minimum of 4 months
information regarding changes in recom-
RCT = randomized controlled trial. mendations for the use of cough and cold
medications in children. Search dates:
Information from references 6, 18, 31, 46, 47, 49, and 69.
September 5 to November 28, 2018, and
February 18 to July 17, 2019.
September 1, 2019 ◆ Volume 100, Number 5 [Link]/afp American Family Physician 287
COMMON COLD
14. Seida JK, Durec T, Kuhle S. North American (Panax quinquefolius) and
The Authors Asian ginseng (Panax ginseng) preparations for prevention of the com-
mon cold in healthy adults: a systematic review. Evid Based Comple-
KATHARINE C. DEGEORGE, MD, MS, is an associate profes- ment Alternat Med. 2011;2011:282151.
sor of family medicine, assistant director of the Family Medi- 15. Simancas-Racines D, Franco JV, Guerra CV, et al. Vaccines for the com-
cine Residency Program, and associate director of the Faculty mon cold. Cochrane Database Syst Rev. 2017;(5):CD002190.
Development Fellowship at the University of Virginia Depart- 16. Hemilä H, Chalker E. Vitamin C for preventing and treating the common
ment of Family Medicine, Charlottesville. cold. Cochrane Database Syst Rev. 2013;(1):CD000980.
17. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementa-
DANIEL J. RING, MD, is a third-year family medicine resident tion to prevent acute respiratory tract infections: systematic review and
at the University of Virginia Department of Family Medicine. meta-analysis of individual participant data. BMJ. 2017;356:i6583.
18. Aglipay M, Birken CS, Parkin PC, et al.; TARGet Kids! Collaboration.
SARAH N. DALRYMPLE, MD, is an assistant professor of fam- Effect of high-dose vs standard-dose wintertime vitamin D supplemen-
ily medicine at the University of Virginia Department of Fam- tation on viral upper respiratory tract infections in young healthy chil-
ily Medicine. dren. JAMA. 2017;318(3):245-254.
19. Murdoch DR, Slow S, Chambers ST, et al. Effect of vitamin D3 supple-
Address correspondence to Katharine C. DeGeorge, MD, MS, mentation on upper respiratory tract infections in healthy adults: the
University of Virginia School of Medicine, Box 800729, Char- VIDARIS randomized controlled trial. JAMA. 2012;308(13):1 333-1339.
lottesville, VA 22908 (email:kd6fp@[Link]). Reprints are 20. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respira-
not available from the authors. tory tract infections. Cochrane Database Syst Rev. 2015;(2):CD006895.
21. Satomura K, Kitamura T, Kawamura T, et al.; G reat Cold Investigators-I.
Prevention of upper respiratory tract infections by gargling: a
random-
References ized trial. Am J Prev Med. 2005;29(4):302-307.
1. Centers for Disease Control and Prevention;National Center for Health 22. Li S, Yue J, Dong BR, et al. Acetaminophen (paracetamol) for the com-
Statistics. Current estimates from the National Health Interview Survey, mon cold in adults. Cochrane Database Syst Rev. 2013;(7):CD008800.
1996. Accessed July 17, 2019. https:// w [Link]/nchs/data/series/ 23. De Sutter AI, van Driel ML, Kumar AA, et al. Oral antihistamine-
sr_10/sr10_200.pdf decongestant-analgesic combinations for the common cold. Cochrane
2. Hay AD, Anderson E, Ingle S, et al. Respiratory tract infections in chil- Database Syst Rev. 2012;(2):CD004976.
dren in the community: prospective online inception cohort study. Ann 24. Holmes PW, Barter CE, Pierce RJ. Chronic persistent cough: u se of
Fam Med. 2019;17(1):14-22. ipratropium bromide in undiagnosed cases following upper respiratory
3. Kirkpatrick GL. The common cold. Prim Care. 1996;23(4):657-675. tract infection. Respir Med. 1992;86(5):425-429.
4. Ebell MH, Lundgren J, Youngpairoj S. How long does a cough last? 25. Deckx L, De Sutter AI, Guo L, et al. Nasal decongestants in monother-
Comparing patients’ expectations with data from a systematic review apy for the common cold. Cochrane Database Syst Rev. 2016;(10):
of the literature. Ann Fam Med. 2013;11(1):5-13. CD009612.
5. U.S. Food and Drug Administration. Use caution when giving cough 26. Guillemard E, Tondu F, Lacoin F, et al. Consumption of a fermented
and cold products to kids. Accessed November 21, 2018. https:// w ww. dairy product containing the probiotic Lactobacillus casei DN-114001
[Link]/Drugs/ResourcesForYou/SpecialFeatures/[Link] reduces the duration of respiratory infections in the elderly in a ran-
6. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications domised controlled trial. Br J Nutr. 2010;103(1):58-68.
for acute cough in children and adults in community settings. Cochrane 27. Kim SY, Chang YJ, Cho HM, et al. Non-steroidal anti-inflammatory
Database Syst Rev. 2014;(11):CD001831. drugs for the common cold. Cochrane Database Syst Rev. 2015;(9):
7. Centers for Disease Control and Prevention. Antibiotic use in the United CD006362.
States, 2017: p
rogress and opportunities. Accessed June 19, 2019. [Link] 28. Hemilä H, Chalker E. The effectiveness of high dose zinc acetate loz-
[Link]/antibiotic-use/stewardship-report/pdf/stewardship- enges on various common cold symptoms: a meta-analysis. BMC Fam
[Link] Pract. 2015;16:24.
8. Jefferson T, Del Mar CB, Dooley L, et al. Physical interventions to inter- 29. Hemilä H. Zinc lozenges and the common cold: a meta-analysis com-
rupt or reduce the spread of respiratory viruses. Cochrane Database paring zinc acetate and zinc gluconate, and the role of zinc dosage.
Syst Rev. 2011;(7):CD006207. JRSM Open. 2017;8(5):2054270417694291.
9. Hübner NO, Hübner C, Wodny M, et al. Effectiveness of alcohol-based 30. Science M, Johnstone J, Roth DE, et al. Zinc for the treatment of the
hand disinfectants in a public administration: impact on health and common cold: a systematic review and meta-analysis of randomized
work performance related to acute respiratory symptoms and diar- controlled trials. CMAJ. 2012;184(10):E551-E561.
rhoea. BMC Infect Dis. 2010;10:250. 31. Little P, Moore M, Kelly J, et al.; PIPS Investigators. Ibuprofen, para-
10. Dyer DL, Shinder A, Shinder F. Alcohol-free instant hand sanitizer reduces cetamol, and steam for patients with respiratory tract infections in pri-
elementary school illness absenteeism. Fam Med. 2000;32(9):633-638. mary care: p ragmatic randomised factorial trial. BMJ. 2013;347:f6041.
11. Chamberlain AN, Halablab MA, Gould DJ, et al. Distribution of bacteria 32. Reinecke S, Tschaikin M. Investigation of the effect of oxymetazoline
on hands and the effectiveness of brief and thorough decontamina- on the duration of rhinitis. results of a placebo-controlled double-blind
tion procedures using non-medicated soap. Zentralbl Bakteriol. 1997; study in patients with acute rhinitis [in German]. MMW Fortschr Med.
285(4):565-575. 2005;147(suppl 3):113-118.
12. Todd EC, Michaels BS, Smith D, et al. Outbreaks where food workers 33. Dykewicz MS, Fineman S, Skoner DP, et al.; American Academy of
have been implicated in the spread of foodborne disease. Part 9. Wash- Allergy, Asthma, and Immunology. Diagnosis and management of rhi-
ing and drying of hands to reduce microbial contamination. J Food nitis: c
omplete guidelines of the Joint Task Force on Practice Parame-
Prot. 2010;73(10):1937-1955. ters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol.
13. Aiello AE, Coulborn RM, Perez V, et al. Effect of hand hygiene on infec- 1998;81(5 pt 2):478-518.
tious disease risk in the community setting: a meta-analysis. Am J Pub- 34. De Sutter AI, Saraswat A, van Driel ML. Antihistamines for the common
lic Health. 2008;98(8):1 372-1381. cold. Cochrane Database Syst Rev. 2015;(11):CD009345.
288 American Family Physician [Link]/afp Volume 100, Number 5 ◆ September 1, 2019
COMMON COLD
35. Klimek L, Schumacher H, Schütt T, et al. Factors associated with effi- 55. Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of inappro-
cacy of an ibuprofen/pseudoephedrine combination drug in pharmacy priate antibiotic prescriptions among US ambulatory care visits, 2010-
customers with common cold symptoms. Int J Clin Pract. 2017;71(2): 2011. JAMA. 2016;315(17):1864-1873.
e12907. 56. Singh M, Singh M, Jaiswal N, et al. Heated, humidified air for the com-
36. Bolser DC. Cough suppressant and pharmacologic protussive therapy: mon cold. Cochrane Database Syst Rev. 2017;(8):CD001728.
ACCP evidence-based clinical practice guidelines. Chest. 2006;129 57. Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the
(1 suppl):238S-249S. common cold. Planta Med. 2008;74(6):633-637.
37. Zanasi A, Lecchi M, Del Forno M, et al. A randomized, placebo- 58. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the
controlled, double-blind trial on the management of post-infective common cold: a randomized, double-blind, placebo-controlled clini-
cough by inhaled ipratropium and salbutamol administered in combi- cal trial. Arch Intern Med. 2004;164(11):1237-1241.
nation. Pulm Pharmacol Ther. 2014;29(2):224-232.
59. Wong T, Stang AS, Ganshorn H, et al. Combined and alternating parac-
38. Prasad AS, Fitzgerald JT, Bao B, et al. Duration of symptoms and plasma etamol and ibuprofen therapy for febrile children. Cochrane Database
cytokine levels in patients with the common cold treated with zinc ace- Syst Rev. 2013;(10):CD009572.
tate. A randomized, double-blind, placebo-controlled trial. Ann Intern
60. Paul IM, Beiler J, McMonagle A, et al. Effect of honey, dextromethor-
Med. 2000;1 33(4):245-252.
phan, and no treatment on nocturnal cough and sleep quality for
39. King D, Mitchell B, Williams CP, et al. Saline nasal irrigation for acute coughing children and their parents. Arch Pediatr Adolesc Med. 2007;
upper respiratory tract infections. Cochrane Database Syst Rev. 161(12):1 140-1146.
2015;(4):CD006821.
61. Oduwole O, Udoh EE, Oyo-Ita A, et al. Honey for acute cough in chil-
40. Guppy MP, Mickan SM, Del Mar CB, et al. Advising patients to increase dren. Cochrane Database Syst Rev. 2018;(4):CD007094.
fluid intake for treating acute respiratory infections. Cochrane Database
62. AlBalawi ZH, Othman SS, Alfaleh K. Intranasal ipratropium bromide for
Syst Rev. 2011;(2):CD004419.
the common cold. Cochrane Database Syst Rev. 2013;(6):CD008231.
41. Chalumeau M, Duijvestijn YC. Acetylcysteine and carbocysteine for
63. Slapak I, Skoupá J, Strnad P, et al. Efficacy of isotonic nasal wash (sea-
acute upper and lower respiratory tract infections in paediatric patients
water) in the treatment and prevention of rhinitis in children. Arch Oto-
without chronic broncho-pulmonary disease. Cochrane Database Syst
laryngol Head Neck Surg. 2008;134(1):67-74.
Rev. 2013;(5):CD003124.
64. Paul IM, Beiler JS, King TS, et al. Vapor rub, petrolatum, and no treat-
42. Josling P. Preventing the common cold with a garlic supplement:
ment for children with nocturnal cough and cold symptoms. Pediatrics.
a double-blind, placebo-controlled survey. Adv Ther. 2001;18(4):
2010;126(6):1092-1099.
189-193.
65. Kenia P, Houghton T, Beardsmore C. Does inhaling menthol affect nasal
43. Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold.
patency or cough? Pediatr Pulmonol. 2008;43(6):532-537.
Cochrane Database Syst Rev. 2014;(11):CD006206.
66. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common
44. Li G, Cai L, Jiang H, et al. Compound formulas of traditional Chinese med-
colds by zinc gluconate lozenges in a double-blind study. Antimicrob
icine for the common cold: systematic review of randomized, placebo-
Agents Chemother. 1984;25(1):20-24.
controlled trials. Altern Ther Health Med. 2015;21(6):48-57.
67. Macknin ML, Piedmonte M, Calendine C, et al. Zinc gluconate lozenges
45. Zhang X, Wu T, Zhang J, et al. Chinese medicinal herbs for the common
for treating the common cold in children: a randomized controlled trial.
cold. Cochrane Database Syst Rev. 2007;(1):CD004782.
JAMA. 1998;279(24):1962–1967.
46. Spurling GK, Del Mar CB, Dooley L, et al. Delayed antibiotic prescrip-
68. Singh M, Das RR. Withdrawn: zinc for the common cold. Cochrane
tions for respiratory infections. Cochrane Database Syst Rev. 2017;(9):
Database Syst Rev. 2015;(4):CD001364.
CD004417.
69. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of
47. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent
childhood. Cochrane Database Syst Rev. 2000;(2):CD001107.
rhinitis. Cochrane Database Syst Rev. 2013;(6):CD000247.
70. Taylor JA, Novack AH, Almquist JR, et al. Efficacy of cough suppres-
48. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine
sants in children. J Pediatr. 1993;122(5 pt 1):799-802.
in cough associated with common cold. J Pharm Pharmacol. 1997;
49(10):1045-1049. 71. Paul IM, Yoder KE, Crowell KR, et al. Effect of dextromethorphan,
diphenhydramine, and placebo on nocturnal cough and sleep quality
49. Karsch-Völk M, Barrett B, Kiefer D, et al. Echinacea for preventing and
for coughing children and their parents. Pediatrics. 2004;114(1):e85-e90.
treating the common cold. Cochrane Database Syst Rev. 2014;(2):
CD000530. 72. Bernard DW, Goepp JG, Duggan AK, et al. Is oral albuterol effective
for acute cough in non-asthmatic children? Acta Paediatr. 1999;88(4):
50. Hayward G, Thompson MJ, Perera R, et al. Corticosteroids for the com-
465-467.
mon cold. Cochrane Database Syst Rev. 2015;(10):CD008116.
73. Becker LA, Hom J, Villasis-Keever M, et al. Beta2-agonists for acute
51. Timmer A, Günther J, Motschall E, et al. Pelargonium sidoides extract
cough or a clinical diagnosis of acute bronchitis. Cochrane Database
for treating acute respiratory tract infections. Cochrane Database Syst
Syst Rev. 2015;(9):CD001726.
Rev. 2013;(10):CD006323.
74. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea
52. Barrett BP, Brown RL, Locken K, et al. Treatment of the common cold
in treating upper respiratory tract infections in children: a randomized
with unrefined echinacea. A randomized, double-blind, placebo-
controlled trial. JAMA. 2003;290(21):2824-2830.
controlled trial. Ann Intern Med. 2002;137(12):939-946.
75. Fashner J, Ericson K, Werner S. Treatment of the common cold in chil-
53. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-
dren and adults. Am Fam Physician. 2012;86(2):153-159. Accessed June
mineral supplementation on acute respiratory tract infections in elderly
19, 2019. https:// w [Link]/afp/2012/0715/[Link]
persons: a randomized controlled trial. JAMA. 2002;288(6):715-721.
76. Simasek M, Blandino DA. Treatment of the common cold. Am Fam Phy-
54. Malesker MA, Callahan-Lyon P, Ireland B, et al.; CHEST Expert Cough
sician. 2007;75(4):515-520. Accessed June 19, 2019. https:// w [Link].
Panel. Pharmacologic and nonpharmacologic treatment for acute
org/afp/2007/0215/[Link]
cough associated with the common cold. Chest. 2017;152(5):1021-1037.
September 1, 2019 ◆ Volume 100, Number 5 [Link]/afp American Family Physician 289
Steam treatments, including the use of heated, humidified air, do not show significant benefits for the treatment of upper respiratory infections in both adults and children, with no improvement observed in cold symptoms .
High-quality studies, including a Cochrane review, have shown that echinacea is not more effective than placebo in reducing the duration or severity of common cold symptoms .
Two Cochrane reviews conclude that antibiotics provide no benefit in the treatment of common cold symptoms in both children and adults in terms of alleviating severity or shortening duration .
Intranasal corticosteroids are not more effective than a placebo in reducing symptom severity or duration of common cold symptoms in both adults and children .
High-dose vitamin D supplementation does not significantly affect the occurrence, duration, or severity of upper respiratory tract infections in adults, nor does it reduce work absenteeism related to URIs .
Antihistamines, whether administered alone or in combination with a decongestant, show no significant effectiveness over placebo in treating the common cold in children in terms of alleviating cough symptoms .
Increasing fluid intake in children with upper respiratory tract infections is not supported by high-quality evidence and can actually cause harm according to low-quality studies .
Codeine and similar opioid antitussives have not demonstrated effectiveness for treating acute cough in adults compared to a placebo, as both the codeine and placebo groups experienced significant reductions in cough frequency and severity .
Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 has been shown to reduce the duration of respiratory infections in the elderly in a randomized controlled trial .
Systematic reviews have concluded that vitamin C does not significantly affect the duration or severity of common cold symptoms once they have developed, showing no more benefit than a placebo .